Novo Nordisk Research Center Gladsaxe ApS — Credit Rating and Financial Key Figures
CVR number: 39119374
Novo Alle 1, 2880 Bagsværd
Income statement (kDKK)
2019 | 2020 | 2021 | 2022 | 2023 | |
|---|---|---|---|---|---|
| Fiscal period length | 12 | 12 | 12 | 12 | 12 |
| Net sales | |||||
| Other operating income | 514 961.00 | ||||
| Gross profit | 25 623.83 | 10 676.60 | 514 961.00 | ||
| Costs of management | - 343.31 | - 202.38 | - 331.55 | -60.00 | - 197.00 |
| Other operating expenses | -6 726.99 | -6 397.54 | -7 052.52 | ||
| Total depreciation | - 716.20 | - 718.01 | - 690.24 | ||
| EBIT | 18 553.53 | 4 076.68 | -7 384.07 | -60.00 | 514 764.00 |
| Other financial income | 2.26 | 0.93 | 1.18 | 2 053.00 | |
| Other financial expenses | -54.31 | - 159.57 | - 299.03 | -2 133.00 | -9 260.00 |
| Pre-tax profit | 18 501.48 | 3 918.05 | -7 681.92 | -1 040.00 | 507 557.00 |
| Income taxes | -4 075.37 | - 732.99 | 1 485.61 | -1 153.00 | - 111 353.00 |
| Profit/loss from discontinued operations | -6 637.00 | - 729.00 | |||
| Net earnings | 14 426.11 | 3 185.06 | -6 196.31 | -8 830.00 | 395 475.00 |
Assets (kDKK)
2019 | 2020 | 2021 | 2022 | 2023 | |
|---|---|---|---|---|---|
| Intangible rights | 27.78 | ||||
| Intangible assets total | 27.78 | ||||
| Machinery and equipment | 2 747.67 | 2 211.41 | 1 521.17 | ||
| Tangible assets total | 2 747.67 | 2 211.41 | 1 521.17 | ||
| Investments total | |||||
| Long term receivables total | |||||
| Inventories total | |||||
| Current amounts owed by group member comp. | 516 985.00 | ||||
| Current other receivables | 190.51 | 348.00 | |||
| Current deferred tax assets | 207.62 | 333.10 | 1 341.54 | 1 153.00 | |
| Short term receivables total | 207.62 | 333.10 | 1 532.06 | 1 501.00 | 516 985.00 |
| Cash and bank deposits | 25 247.50 | 9 160.50 | 7 640.00 | 6 276.00 | 3.00 |
| Cash and cash equivalents | 25 247.50 | 9 160.50 | 7 640.00 | 6 276.00 | 3.00 |
| Balance sheet total (assets) | 28 230.57 | 11 705.01 | 10 693.23 | 7 777.00 | 516 988.00 |
Equity and liabilities (kDKK)
2019 | 2020 | 2021 | 2022 | 2023 | |
|---|---|---|---|---|---|
| Share capital | 51.52 | 51.52 | 51.52 | 52.00 | 52.00 |
| Shares repurchased | 12 000.00 | 405 000.00 | |||
| Retained earnings | -8 175.46 | 6 250.65 | 9 085.72 | 2 889.00 | - 394 942.00 |
| Profit of the financial year | 14 426.11 | 3 185.06 | -6 196.31 | -8 830.00 | 395 475.00 |
| Shareholders equity total | 18 302.17 | 9 487.23 | 2 940.92 | -5 889.00 | 405 585.00 |
| Provisions | 144.06 | ||||
| Non-current owed to group member | 5 377.14 | 8 608.00 | |||
| Non-current other liabilities | 340.57 | 486.78 | 428.63 | ||
| Non-current deferred tax liabilities | 488.00 | ||||
| Non-current liabilities total | 340.57 | 486.78 | 5 805.77 | 9 096.00 | |
| Current loans from credit institutions | 908.78 | 3 762.00 | |||
| Current trade creditors | 122.83 | 26.18 | 517.12 | 352.00 | 50.00 |
| Current owed to participating | 112.37 | 121.51 | 131.36 | 142.00 | |
| Short-term deferred tax liabilities | 4 043.73 | 111 353.00 | |||
| Other non-interest bearing current liabilities | 4 241.24 | 1 439.25 | 380.16 | 314.00 | |
| Accruals and deferred income | 1 067.66 | 9.11 | |||
| Current liabilities total | 9 587.84 | 1 586.94 | 1 946.54 | 4 570.00 | 111 403.00 |
| Balance sheet total (liabilities) | 28 230.57 | 11 705.01 | 10 693.23 | 7 777.00 | 516 988.00 |
Try the full version of our system for free
- Professional credit risk reports
- Create your own estimates for any company
- Valuation analysis
- All 400,000+ Danish companies
- See instructions
... and more!
No registration needed.